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Background
Male breast cancer (MBC) is a rare tumor and accounts
for <1 % of all breast cancers, but its incidence is
increasing. The majority of breast lesions in men are
benign and the causes, optimal treatments, and medical/
psychosocial sequelae of breast cancer in men are poorly
understood. [1] The natural history and prognostic fac-
tors do not differ from the female form, this tumor is
characterized by a higher mortality rate because the pre-
senting symptoms are often underestimated, and it
comes to diagnosis when the disease is already advanced
[2].
Methods
In our study we retrospectively analyzed the clinico-
pathologic features and prognosis of 16 cases of male
breast cancer diagnosed in our hospital from 1998 to
2010, and we assessed whether prognostic factors in
male (MBC) and female (FBC) breast cancer have simi-
lar impact on survival: the aim of our study was to com-
pare overall survival (OS) and disease-free survival (DFS)
in a group of matched males and females with breast
cancer with similar prognostic factors (including age,
nodal status, resection margin, use of hormonal therapy,
chemotherapy with/without hormone and radiation
therapy).
Results
Matching was conducted based on age, year of diagno-
sis, stage of the disease and pathology. The mean age at
diagnosis was 60.0±11.3 years for males and 56.1±10.6
years for females, and the median follow-up time was 54
months (range, 5-242 months) for males and 60 months
(range, 29-263 months) for females. The invasive ductal
carcinoma in MBC was much higher than in FBC. The
positive rate of estrogen receptors in MBC patients was
higher than in FBC patients (P = 0.048), whereas HER-2
was positive in 13.8 % of MBC patients, which was sig-
nificantly lower than in FBC patients (P = 0.001); HER-
2-positive patients had a statistically worse prognosis
than HER-2-negative patients (P = 0.040). The overall
survival rates of MBC were significantly higher than
FBC. Lymph node metastases and larger tumor size
were also associated with poorer prognosis. Not statisti-
cally significant differences were identified for tumor
location between the two groups.
Conclusions
BRCA2 mutations, lower age, lymph nodes metastases
and tumor size are proven risk factors. The FBC
patients were significantly different from the MBC in
clinicopathologic and prognostic characteristics: the
HER-2 positivity, much higher in women, was an impor-
tant factor for bad prognosis [3,4] . Disease biology is
distinct in men, but diagnostic approaches and treat-
ments for men are generally extrapolated from those in
women due to inadequate research in men.
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